206A.T
Price:
$266
Market Cap:
$9.75B
PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.
Industry
Biotechnology
IPO Date
2024-07-02
Stock Exchange
JPX
Ticker
206A.T
According to PRISM BioLab Co.,LTD’s latest financial reports and current stock price. The company's current PE Ratio is -7.93. This represents a change of -21.50% compared to the average of -10.10 of the last 4 quarters.
The mean historical PE Ratio of PRISM BioLab Co.,LTD over the last ten years is -16.80. The current -7.93 PE Ratio has changed 4.62% with respect to the historical average. Over the past ten years (40 quarters), 206A.T's PE Ratio was at its highest in in the March 2024 quarter at 0. The PE Ratio was at its lowest in in the June 2024 quarter at -19.10.
Average
-16.80
Median
-12.23
Minimum
-38.18
Maximum
0
Discovering the peaks and valleys of PRISM BioLab Co.,LTD PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -38.18
Year | PE Ratio | Change |
---|---|---|
2024 | -12.23 | -67.97% |
2023 | -38.18 | -Infinity% |
The current PE Ratio of PRISM BioLab Co.,LTD (206A.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.80
5-year avg
-16.80
10-year avg
-16.80
PRISM BioLab Co.,LTD’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PRISM BioLab Co.,LTD using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PRISM BioLab Co.,LTD or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PRISM BioLab Co.,LTD's PE Ratio?
How is the PE Ratio calculated for PRISM BioLab Co.,LTD (206A.T)?
What is the highest PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
What is the 3-year average PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
What is the 5-year average PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
How does the current PE Ratio for PRISM BioLab Co.,LTD (206A.T) compare to its historical average?